CORRESP Filing
BriaCell Therapeutics Corp.
Date: Jan. 6, 2026 · CIK: 0001610820 · Accession: 0001493152-26-000533
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292388
Letter
BriaCell Therapeutics Corp.
Suite 300 - 235 15th Street
West Vancouver, BC V7T 2X1
January 6, 2026
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street NE
Washington, D.C. 20549
Re: BriaCell Therapeutics Corp. (the "Company")
Registration Statement on Form S-1 (the "Registration Statement")
File No. 333-292388
Ladies and Gentlemen:
The Company hereby requests that the effective date of the above-referenced Registration Statement be accelerated to 5:00 p.m. Eastern Time on January 8, 2026, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time pursuant to Rule 461 under the Securities Act of 1933, as amended.
Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Sichenzia Ross Ference Carmel LLP, by contacting Christian Lichtenberger, Esq. at (212) 997-0962 or clichtenberger@srfc.law.
Very
truly yours,
/s/
William V. Williams
Show Raw Text
CORRESP 1 filename1.htm BriaCell Therapeutics Corp. Suite 300 - 235 15th Street West Vancouver, BC V7T 2X1 January 6, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Re: BriaCell Therapeutics Corp. (the "Company") Registration Statement on Form S-1 (the "Registration Statement") File No. 333-292388 Ladies and Gentlemen: The Company hereby requests that the effective date of the above-referenced Registration Statement be accelerated to 5:00 p.m. Eastern Time on January 8, 2026, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time pursuant to Rule 461 under the Securities Act of 1933, as amended. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Sichenzia Ross Ference Carmel LLP, by contacting Christian Lichtenberger, Esq. at (212) 997-0962 or clichtenberger@srfc.law. Very truly yours, /s/ William V. Williams William V. Williams Chief Executive Officer